Logo image of VXZ

IPATH SER B S&P 500 VIX M/T (VXZ) Stock Price, Forecast & Analysis

USA - NYSEARCA:VXZ - US06748M1889 - ETF

56.97 USD
+0.4 (+0.71%)
Last: 10/31/2025, 8:19:13 PM
Fundamental Rating

3

VXZ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 390 industry peers in the Banks industry. VXZ may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, VXZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

VXZ had positive earnings in the past year.
In the past year VXZ has reported a negative cash flow from operations.
VXZ had positive earnings in each of the past 5 years.
Of the past 5 years VXZ 4 years had a positive operating cash flow.
VXZ Yearly Net Income VS EBIT VS OCF VS FCFVXZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

With a Return On Assets value of 0.59%, VXZ is not doing good in the industry: 71.54% of the companies in the same industry are doing better.
VXZ has a better Return On Equity (12.49%) than 84.10% of its industry peers.
Industry RankSector Rank
ROA 0.59%
ROE 12.49%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.41%
ROIC(3y)N/A
ROIC(5y)N/A
VXZ Yearly ROA, ROE, ROICVXZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

The Profit Margin of VXZ (20.33%) is worse than 63.59% of its industry peers.
In the last couple of years the Profit Margin of VXZ has grown nicely.
VXZ does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 20.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.91%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
VXZ Yearly Profit, Operating, Gross MarginsVXZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

VXZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VXZ has less shares outstanding
The number of shares outstanding for VXZ has been reduced compared to 5 years ago.
Compared to 1 year ago, VXZ has about the same debt to assets ratio.
VXZ Yearly Shares OutstandingVXZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
VXZ Yearly Total Debt VS Total AssetsVXZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.86 is on the high side and indicates that VXZ has dependencies on debt financing.
VXZ's Debt to Equity ratio of 3.86 is on the low side compared to the rest of the industry. VXZ is outperformed by 94.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.37%
VXZ Yearly LT Debt VS Equity VS FCFVXZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
VXZ Yearly Current Assets VS Current LiabilitesVXZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

VXZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.69%, which is quite impressive.
VXZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.00% yearly.
VXZ shows a small growth in Revenue. In the last year, the Revenue has grown by 5.48%.
The Revenue has been growing slightly by 5.03% on average over the past years.
EPS 1Y (TTM)36.69%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%12.77%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.82%
Revenue growth 5Y5.03%
Sales Q2Q%9.47%

3.2 Future

Based on estimates for the next years, VXZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.69% on average per year.
VXZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y8.76%
EPS Next 2Y15.3%
EPS Next 3Y14.66%
EPS Next 5Y8.69%
Revenue Next Year8.62%
Revenue Next 2Y6.67%
Revenue Next 3Y5.63%
Revenue Next 5Y4.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VXZ Yearly Revenue VS EstimatesVXZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
VXZ Yearly EPS VS EstimatesVXZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.16 indicates a rather expensive valuation of VXZ.
VXZ's Price/Earnings ratio is rather expensive when compared to the industry. VXZ is more expensive than 82.56% of the companies in the same industry.
When comparing the Price/Earnings ratio of VXZ to the average of the S&P500 Index (26.10), we can say VXZ is valued inline with the index average.
The Price/Forward Earnings ratio is 20.86, which indicates a rather expensive current valuation of VXZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VXZ indicates a slightly more expensive valuation: VXZ is more expensive than 78.46% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of VXZ to the average of the S&P500 Index (22.52), we can say VXZ is valued inline with the index average.
Industry RankSector Rank
PE 23.16
Fwd PE 20.86
VXZ Price Earnings VS Forward Price EarningsVXZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXZ Per share dataVXZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as VXZ's earnings are expected to grow with 14.66% in the coming years.
PEG (NY)2.64
PEG (5Y)2.11
EPS Next 2Y15.3%
EPS Next 3Y14.66%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.09%, VXZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.52, VXZ is paying slightly less dividend.
VXZ's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

The dividend of VXZ is nicely growing with an annual growth rate of 6.61%!
VXZ does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)6.61%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The dividend of VXZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y15.3%
EPS Next 3Y14.66%
VXZ Yearly Income VS Free CF VS DividendVXZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

IPATH SER B S&P 500 VIX M/T

NYSEARCA:VXZ (10/31/2025, 8:19:13 PM)

56.97

+0.4 (+0.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners55.08%
Inst Owner Change0%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap198.69B
Revenue(TTM)47.27B
Net Income(TTM)9.48B
Analysts79.09
Price Target61.36 (7.71%)
Short Float %0%
Short Ratio6.71
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend0.81
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.25%
PT rev (3m)-6.56%
EPS NQ rev (1m)-8.37%
EPS NQ rev (3m)-10.8%
EPS NY rev (1m)-4.8%
EPS NY rev (3m)-5.66%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 23.16
Fwd PE 20.86
P/S 3.25
P/FCF N/A
P/OCF N/A
P/B 2
P/tB 2.24
EV/EBITDA N/A
EPS(TTM)2.46
EY4.32%
EPS(NY)2.73
Fwd EY4.79%
FCF(TTM)-3.82
FCFYN/A
OCF(TTM)-3.82
OCFYN/A
SpS17.52
BVpS28.52
TBVpS25.45
PEG (NY)2.64
PEG (5Y)2.11
Graham Number39.73
Profitability
Industry RankSector Rank
ROA 0.59%
ROE 12.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.33%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.91%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.69%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%12.77%
EPS Next Y8.76%
EPS Next 2Y15.3%
EPS Next 3Y14.66%
EPS Next 5Y8.69%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.82%
Revenue growth 5Y5.03%
Sales Q2Q%9.47%
Revenue Next Year8.62%
Revenue Next 2Y6.67%
Revenue Next 3Y5.63%
Revenue Next 5Y4.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A

IPATH SER B S&P 500 VIX M/T / VXZ FAQ

What does IPATH SER B S&P 500 VIX M/T do?

Barclays PLC is a bank holding company, which engages in the provision of retail banking, credit cards, corporate and investment banking, and wealth management services. The Barclays UK division represents businesses that sit within the United Kingdom ring-fenced bank, Barclays Bank UK PLC and its subsidiaries, and comprises Personal Banking, UK Business Banking and Barclaycard Consumer UK. The Barclays UK Corporate Bank division offers lending, trade and working capital, liquidity, payments, and FX solutions for corporate clients. Barclays Private Bank and Wealth Management division comprises the Private Bank, Wealth Management, and Investments businesses. Barclays Investment Bank division incorporates the Global Markets, Investment Banking, and International Corporate Banking businesses. Barclays US Consumer Bank division represents the United States credit card business, focused on the partnership market, as well as an online deposit franchise.


What is the stock price of IPATH SER B S&P 500 VIX M/T today?

The current stock price of VXZ is 56.97 USD. The price increased by 0.71% in the last trading session.


How is the ChartMill rating for IPATH SER B S&P 500 VIX M/T?

VXZ has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.